This snapshot taken on 05/02/2008, shows web content selected for preservation by The National Archives. External links, forms and search boxes may not work in archived websites.
Please note that this website has a UK government access keys system.
This section contains professional letters and 'dear colleague' letters from the Chief Medical Officer to the NHS.
Letter addressing concerns over the possible under-reporting of HCAI as a cause of death, and reinforcing the message that death certification is a significant responsibility for doctors and should reflect a careful consideration of all the events that led up to, and may have caused or contributed to, the person’s death.
This letter from Sir Liam Donaldson, Chief Medical Officer, outlines the 'Keep Warm Keep Keep Well' campaign for winter 2007/08. The 'Keep Warm Keep Well' campaign aims to provide useful advice on how to stay healthy in the winter months, together with information about financial and practical help that is available. The campaign is particularly aimed at older people, and those who have chronic illness or who are vulnerable to illness due to disability.
This Professional Letter provides information on the new funding for HCAIs announced on 4 July 2007, via SHA Directors of Nursing, and reminds staff of new reporting arrangements for Clostridium difficile infection.
This letter explains a Haemophilus influenzae type b (Hib) vaccination catch-up programme, which will start on 10 September 2007 and continue until 3 March 2009.
This letter from Chief Medical Officer, Sir Liam Donaldson, gives recommendations of the expert working group on the prevention of venous VTE in hospitalised patients.
A web-based system for the surveillance of Clostridium difficile associated diarrhoea (CDAD) is being introduced in April 2007 and Trusts will have to enter all cases in individuals aged two years and over on to this new system (subject to Review of Central Returns (ROCR) approval).
This letter provides information on the influenza immunisation programme 2007/2008.
This letter is a reminder that centres providing neurological and eye surgery should be developing arrangements to implement the NICE guidance and sets out the Department’s plans to issue further advice on decontamination in 2007.
The CMO is writing to remind neurologists to remain vigilant and to refer unusual neurological cases through the established national arrangements for referral and reporting of suspected cases of human prion disease (CJD).
MRSA colonisation is a risk factor present in a significant proportion of the patient population. For this reason trusts are advised to review their strategies for screening and decolonisation of patients with MRSA carriage immediately. In support of this the enclosed screening strategy has been devised to help with practical interventions.
This letter, sent to Government Office Regional Directors and Strategic Health Authority Chief Executives, describes the new national framework for the DH's regional presence. It also and seeks their help in developing a framework for the work of the DH's enhanced regional presence in 2007/8.
This CMO letter provides further information about changes to the routine childhood immunisation programme.
This letter from the Chief Medical Officer announces the appointments of the Directors of Public Health. They will have a key role in future public health leadership, and will be an asset to the Strategic Health Authority (SHA) and the Government Office Boards.
This letter reports on the coverage achieved by the 2005/2006 influenza vaccination programme, thanking health professionals for their hard work and commitment in achieving such a positive outcome, and informing them about the plans for the 2006/2007 programme.
This letter announces the re-issue of the updated Heatwave Plan for England, first launched July 2004. The Plan's purpose is to enhance resilience in the event of a heatwave. It is an important component of overall emergency planning.
This letter sets out forthcoming changes to arrangements for the collection and checking of the MRSA data returns submitted by acute Trusts.
This letter reminds Trusts of (1) the requirements of the mandatory surveillance scheme operated on behalf of the Department of Health by the Health Protection Agency (HPA), (2) recommendations for microbiological investigation of outbreaks, and (3) the need for policies and procedures to be in place to minimise the risk of C. difficile infection and implement control policies when cases occur.
Following consultation in 2004, the Department of Health has decided not to ask the NHS to implement advice from the Advisory Group on Hepatitis (AGH) about a limited relaxation of restrictions on hepatitis B infected health care workers. This letter from Sir Liam Donaldson, on behalf of the UK Chief Medical Officers, provides further information on the outcome of the consultation.
The Chief Medical Officer was asked, by the Secretary of State for Health, to investigate the handling of late abortion cases by the British Pregnancy Advisory Service (BPAS). His report makes a number of best practice recommendations for dealing with late gestation abortion cases and improving early access to services.
This letter from the Chief Medical Officer, the Chief Nursing Officer and the Chief Pharmaceutical Officer describes the 2005 Influenza immunisation campaign.
This letter from the CMO outlines the Government's response to the HSC's Report on the Prevention of Venous Thromboembolism in Hospitalised Patients, published earlier this year. It includes the HSC's recommendations on the implementation of, and adherence to, guidelines relating to thromboprophylaxis, counselling and risk assessment.
This letter from the CMO outlines the Government's response to the HSC's Report on the Prevention of Venous Thromboembolism in Hospitalised Patients, published earlier this year. It summarises the key findings; announces the establishment of a Working Group, and highlights a selection of key existing guidelines.
This letter describes changes being introduced to the BCG vaccination programme. It outlines an improved targeted neonatal and other at-risk based programme which will replace the current schools' programme for older children.
The UK Advisory Committee on the Microbiological Safety of Blood and Tissues and Organs (MSBTO; previously MSBT) has discussed the potential vCJD transmission risk arising from people who have received blood transfusions since 1 January 1980 and have recommended that living donors should be excluded from donating femoral heads. The Secretary of State for Health has now formally agreed this.
The Chief Medical Officer and Chief Nursing Officer have issued a letter with new guidance on mandatory surveillance of MRSA bacteraemias, including monthly reporting to the HPA and an enhanced surveillance system for MRSA to be rolled out to all acute Trusts by October 2005.
This letter describes the pneumococcal immunisation campaign for 2005.
Letter from the Chief Medical Officer, Sir Liam Donaldson which, informs recipients that the guidance currently in force in England is that issued by the Department of Health in December 2001. together with the NICE (National Institute for Clinical Excellence) interim guidance of March 2004.
This letter describes this year's influenza immunisation campaign and updates you on changes to the recommendations for pneumococcal immunisation.
This letter provides important information about forthcoming changes to the vaccines provided for the routine childhood immunisation programme in England. These changes are being made following the recommendation of the Joint Committee on Vaccination and Immunisation (JCVI).
This letter gives guidance on patient referral to the first UK clinical trial of potential therapy for Creutzfeldt-Jakob Disease (CJD).
A brain biopsy can reveal a diagnosis of CJD that was not suspected prior to the biopsy because CJD can present in atypical ways with a differential diagnosis that includes conditions such as cerebral vasculitis. The biopsy could result in inadvertent exposure of subsequent patients to CJD agent via the instruments used. The Department of Health has taken expert advice on the need for additional guidance for the quarantine of surgical instruments following brain biopsies in such circumstances.
This letter notifies recipients of a programme of action, in the interests of patient safety, to achieve consistency in the naming of medicinal substances.
Varicella immunisation is now recommended for non-immune health care workers (HCWs), who work in primary care and in hospitals (both in the NHS and privately) and who have direct patient contact.
From the beginning of October 2003, sero-negative women of child-bearing age and health care workers who need to be protected against rubella will be offered the combined measles-mumps-rubella (MMR) vaccine. This is because we are unable to secure supplies of licensed rubella vaccine.
Introduction of a pneumococcal immunisation programme for those aged 80 years and over; and influenza immunisation programme 2003/2004.
This letter draws attention to the guide "What to do if you're worried a child is being abused". The guide sets out processes for safeguarding children.
This circular provides notification of the next tranche of the mandatory surveillance scheme for healthcare associated infections.
This letter provides information on new funding for promoting prudent antibiotic prescribing through enhanced clinical pharmacy activity.
This follows the professional letter of 17 February 2003 and provides detailed advice on how the campaign will be implemented.
This letter provides advanced notice of the plans of the Department of Health to introduce a Haemophilus influenzae b (Hib) vaccine catch-up campaign.
This circular contains details of this year's influenza immunisation programme and also important information on other vaccines
This provides information on the appraisal programme for general practioners which will be launched in April 2002
Update of the CMO letter of September 1998 on CO poisoning: the main sources of CO in the home, signs and symptoms which should be looked for, investigations which may be necessary to establish whether a case of CO poisoning has occurred, guidance on how cases should be managed; and sources of further advice and information.
Information on the extension of the availability of the meningitis C vaccine to people up to and including 24 years of age. Also included is revised advice on under the use of pneumococcal vaccine in at-risk groups aged 2 years.
Update on several important immunisation issues, namely: introduction of a pre-school acellular pertussis booster immunisation; thiomersal in vaccines; MMR vaccine update; current meningitis issues (prevention of meningococcal infection associated with the annual Hajj pilgrimage to Saudi Arabia, and winter rise in meningitis).
This letter contains further information and advice for everyone involved in the influenza immunisation programme.
Reminder of the withdrawal by 31 March 2001 of a number of human insulin formulations by Eli Lilly and Company Limited.
This letter informs of the change from 1st April 2001 which will allow buprenorphine to be prescribed and dispensed by instalments for the treatment of drug addiction
Update on several important immunisation issues, namely: MMR; meningitis C; meningococcal immunization for asplenic patients and for pilgrims travelling to Saudi Arabia;influenza immunisation; anaphylaxis management.
This letter provides further information and advice on this year's influenza immunisation campaign.
This guidance sets out a model of good practice to help achieve more responsive, equitable and effective continence services to benefit patients.
From 27 March 2000, the Sure Start Maternity Grant will replace the existing Maternity Paymentscheme and will offer extra help with maternity expenses for parents on low incomes.
Update on some specific issues in relation to vaccination programmes: maintaining continuity of vaccine supply for routine immunisation of infants and young children; encouraging further uptake of plain polysaccharide A + C meningococcal vaccine in first year higher education students; supplies of conjugate meningococcal C vaccine for infant immunisation.
Includes replacement chapter for "Immunisation against infectious disease" 1996.
This letter highlights the first phase of the Government's campaign on antibiotic resistance
A new vaccine will be implemented later this year. Group C meningococcal disease is responsible for 40% of cases of meningococcal disease in this country and is one of the foremost causes of death in children and young people.
A reminder about the importance of early recognition of meningococcal meningitis andsepticaemia, and prompt intervention, with important messages for doctors working in primary care and those providing front line hospital care.
Draws attention to a new report from the Standing Medical Advisory Committee which has important implications for all health professionals who prescribe, dispense, supply and administer or advise on the use of antimicrobial agents.
This letter brings together the most up-to-date information on Carbon monoxide (CO) poisoning. It sets out the main CO sources in the home; describes the signs and symptoms which should be looked for; explains the investigations which may be necessary to establish whether a case of CO poisoning has occurred; describes how cases should be managed; and gives sources of further advice and information.
The Government has accepted a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI) to extend the risk groups recommended to be offered annual influenza immunisation to include all those aged 75 years and older.
Updated guidance and advice on prevention of vitamin K deficiency bleeding in newborn babies.
Information that may help doctors in advising parents.
Further advice on the importance of teaching women to be breast aware and the lack of evidence to support the practice of breast palpation as a screening procedure in the well woman, with guidance on who should perform breast palpation in symptomatic women and as follow-up to breast cancer.
Significance and implications of the recent reports in the media and the medical press of cases of influenza in Hong Kong due to an avian (bird) influenza virus of the A (H5N1) subtype.
Urgent and immediate communications from the Chief Medical Officer (CMO) on public health are transmitted on average four times a year and are most likely to be connected with issues about drugs, infections, vaccines or other public health matters.
The summary report provides valuable information for all those involved in providing HIV/AIDS services and for those responsible for health promotion activities and includes a section on implications for purchasers. I would be grateful if you could ensure that these data are made available to all colleagues as appropriate.
A reminder of the need to consider meningococcal infection in patients with certain symptoms, and guidelines on the management of outbreaks of meningococcal infections.
Summary report from the Unlinked Anonymous Surveys Steering Group givingresults and analysis for samples tested for HIV between 1990 and 1995. It also highlights the key messages from the surveys.
List of influenza vaccines granted product licences for the 1996/7 season by the Medicines Control Agency (MCA).
With effect from October 1996, a second dose of Measles/Mumps/Rubella vaccine (MMR) is to be added to the routine immunisation programme. It is to be given at the same time as the pre-school Diphtheria/Tetanus and Polio vaccine boosters. In addition, a catch-up immunisation programme for MMR is also to commence from that date. These immunisations will, in the main, be delivered by General Practitioners.
Information about the new variant of CJD and with advice to help doctors respond to queries that patients may have following the announcements by the Secretary of State on 20 and 25 March.
The Report shows the maternal mortality rate from conditions directly due to pregnancy (Direct deaths) has fallen for the first time in ten years to 5.5 deaths per 100,000 maternities from 6.0 per 100.000 for the preceding two triennia.
Information and advice about the care of people in the community who have the bacteria MRSA.
The Report shows the maternal mortality rate from conditions directly due to pregnancy (Direct deaths) has fallen for the first time in ten years to 5.5 deaths per 100,000 maternities from 6.0 per 100,000 for the preceding two triennia.
Information on the introduction of the new Specialist Registrar grade, replacing the existing registrar and senior registrar grades on 1 April 1996.
The purpose of this letter is to alert health professionals to the contents of a Government statement about the use of the insecticide Carbaryl which is about to be issued. The point of relevance to health professionals is that Carbaryl is the active constituent in some preparations used for treatment of lice.
Imminent changes to specialist medical training in the UK and to the GMC's registrationarrangements, implementing recommendations in the 1993 report 'Hospital Doctors: Training For The Future'.
List of influenza vaccines granted product licences for the 1995/96 season by theMedicines Control Agency (MCA).
Guidance and procedures for the look back exercise to trace, counsel and, if necessary, treat those people who may have been inadvertently infected with hepatitis C through blood transfusions.
